Table 3.

The list of publications included in this meta-analysis based on the OR value.

Study	Control				Disesase					OR
	N	Age (years)	% of women	Levels	Type of disease	N	Age (years)	% of women	Levels
IL-6
26	622	71.0 (66.0-77.0)	32.5	1.65 ± 1.08	Liver Disease	586	68.0 (64.0-74.0)	80.2	1.58 ± 0.96	4.01 (0.94, 17.14)
44	4532	61.8 ± 10.0)	51.7	1.52 ± 1.21	Intermittent asthma	388	59.7 ± 10.1	60.8	1.60 ± 1.21	1.12 (0.88-1.41)
44	4532	61.8 ± 10.0)	51.7	1.52 ± 1.21	Persistent asthma	109	63.4 ± 9.9	70	1.89 ± 1.61	1.65 (1.08-2.51)
49	68	67.6 ± 11.2	35.3	10.5 ± 17.5	Acute exacerbation	68	70.3 ± 5.8	32.3	35.5 ± 68.3	1.018 (0.999–1.037)
52	1416	71.9 (63.6, 78.4)	47.3	2.5 ± 2.37	Mild cognitive impairment	186	79.7 (73.1-84.7)	40.9	3.1 ± 2.91	1.18 (1.04, 1.34)
52	1416	71.9 (63.6, 78.4)	47.3	2.5 ± 2.37	Mild cognitive impairment	186	79.7 (73.1-84.7)	40.9	3.1 ± 2.91	1.17 (1.01, 1.35)
51	616	85.3 ± 3.3	59	3.25 ± 1.98	Cardiovascular disease	434	86.4 ±4.0	70	3.81 ± 2.80	1.31 (1.11, 1.56)
TNF-alpha
54	165	69.21 ± 9.29	46.67	22.61 ± 29.67	Artial fibrillation	80	69.5 ± 8.87	48.7	30.83 ± 42.39	0.99 (0.99-1.01)
52	1416	71.9 (63.6-78.4)	47.3	4.3 ± 0.89	Mild cognitive impairment	186	79.7 (73.1-84.7)	40.9	3.3 ± 1.64	1.10 (0.96, 1.25) or 1.09 (0.94, 1.28)
52	1416	71.9 (63.6-78.4)	47.3	4.3 ± 0.89	Mild cognitive impairment	186	79.7 (73.1-84.7)	40.9	3.3 ± 1.64	1.10 (0.96, 1.25) or 1.09 (0.94, 1.28)